Literature DB >> 19141080

IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes.

Sanjay K Garg1, Jonathan Kipnis, Ruma Banerjee.   

Abstract

Astrocytes can either exacerbate or ameliorate secondary degeneration at sites of injury in the CNS but the contextual basis for eliciting these opposing phenotypes is poorly understood. In this study, we demonstrate that the two major cytokines produced by Th1 and Th2 cells, interferon-gamma (IFN-gamma), and interleukin-4 (IL-4), respectively, contribute differentially to shaping a neuroprotective response in astrocytes. While IFN-gamma protects the ability of oxidatively stressed murine astrocytes to clear extracellular glutamate in culture, IL-4 has no effect at any concentration that was tested (10-100 ng/mL). The enhanced release of neuroprotective thiols and lactate by astrocytes in response to T cell stimulation is mimicked by both IL-4 and IFN-gamma. When co-administered, IL-4 abrogated the protective effect of low IFN-gamma on the glutamate clearance function of oxidatively stressed astrocytes in a dose-dependent manner. Astrocyte-conditioned media obtained from cells cultured in the presence of IL-4 (10 or 100 ng/mL) or IFN-gamma (10 ng/mL) decreased by approximately 2-fold, neuronal apoptosis induced by oxidative stress in vitro. However, unlike IL-4, IFN-gamma at high concentrations (100 ng/mL) was not neuroprotective. Our studies with IFN-gamma and IL-4 suggest that a balanced Th1 and Th2 cytokine response might be needed for protecting two key astrocytic functions, glutamate clearance and thiol secretion and might be pertinent to neuroprotective approaches that are aimed at inhibition of an initial pro-inflammatory response to injury or its sustained boosting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141080     DOI: 10.1111/j.1471-4159.2009.05872.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

Review 1.  Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?

Authors:  N C Derecki; E Privman; J Kipnis
Journal:  Mol Psychiatry       Date:  2010-02-23       Impact factor: 15.992

2.  Na+ and K+ ion imbalances in Alzheimer's disease.

Authors:  Victor M Vitvitsky; Sanjay K Garg; Richard F Keep; Roger L Albin; Ruma Banerjee
Journal:  Biochim Biophys Acta       Date:  2012-07-20

Review 3.  T cells in the central nervous system: messengers of destruction or purveyors of protection?

Authors:  James T Walsh; Nikki Watson; Jonathan Kipnis
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

4.  Astrocytic redox remodeling by amyloid beta peptide.

Authors:  Sanjay K Garg; Victor Vitvitsky; Roger Albin; Ruma Banerjee
Journal:  Antioxid Redox Signal       Date:  2011-03-28       Impact factor: 8.401

5.  Copper accelerates glycolytic flux in cultured astrocytes.

Authors:  Ivo F Scheiber; Ralf Dringen
Journal:  Neurochem Res       Date:  2011-02-13       Impact factor: 3.996

Review 6.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

7.  DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress.

Authors:  Steven J Mullett; Roberto Di Maio; J Timothy Greenamyre; David A Hinkle
Journal:  J Mol Neurosci       Date:  2012-10-15       Impact factor: 3.444

Review 8.  Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

Authors:  Paula E Goines; Paul Ashwood
Journal:  Neurotoxicol Teratol       Date:  2012-08-17       Impact factor: 3.763

Review 9.  Towards a 'systems'-level understanding of the nervous system and its disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Neurosci       Date:  2013-08-27       Impact factor: 13.837

10.  Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells.

Authors:  Ashley D Reynolds; David K Stone; R Lee Mosley; Howard E Gendelman
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.